Targeting coagulation in heart failure with preserved ejection fraction and cardiac fibrosis

Christoph Hofmann^{1

2}, Mirko Völkers^{1

2}, Hugo A Katus^{1

2}

Affiliations

¹ Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Innere Medizin III, Im Neuenheimer Feld 669, Heidelberg, Germany.
² DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.

Editorial

Christoph Hofmann et al. Eur Heart J. 2019.

. 2019 Oct 21;40(40):3333-3335.

doi: 10.1093/eurheartj/ehz450.

Christoph Hofmann^{1

2}, Mirko Völkers^{1

2}, Hugo A Katus^{1

2}

¹ Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, Innere Medizin III, Im Neuenheimer Feld 669, Heidelberg, Germany.
² DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.

No abstract available

Comment on

Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction.
Friebel J, Weithauser A, Witkowski M, Rauch BH, Savvatis K, Dörner A, Tabaraie T, Kasner M, Moos V, Bösel D, Gotthardt M, Radke MH, Wegner M, Bobbert P, Lassner D, Tschöpe C, Schutheiss HP, Felix SB, Landmesser U, Rauch U. Friebel J, et al. Eur Heart J. 2019 Oct 21;40(40):3318-3332. doi: 10.1093/eurheartj/ehz117. Eur Heart J. 2019. PMID: 31004144